The <i>LMNA </i>p.R541C mutation causes dilated cardiomyopathy in human and mice

Luzi Yang,Jinhuan Sun,Zhan Chen,Lei Liu,Yueshen Sun,Junsen Lin,Xiaomin Hu,Mingming Zhao,Yuanwu Ma,Dan Lu,Yifei Li,Yuxuan Guo,Erdan Dong
DOI: https://doi.org/10.1016/j.ijcard.2022.06.038
IF: 4.039
2022-01-01
International Journal of Cardiology
Abstract:Dilated cardiomyopathy (DCM) is a major cause of heart failure. LMNA variants contribute to 6-10% DCM cases, but the underlying mechanisms remain incompletely understood. Here, we reported two patients carrying the LMNA c.1621C > T/ p.R541C variant and generated a knock-in mouse model (Lmna(RC)) to study the role of this variant in DCM pathogenesis. We found Lmna(RC/RC) mice exhibited ventricular dilation and reduced systolic functions at 6 months after birth. The Lmna(RC/RC) cardiomyocytes increased in size but no nuclear morphology defects were detected. Transcriptomic and microscopic analyses revealed suppressed gene expression and perturbed ultrastructure in Lmna(RC/RC) mitochondria. These defects were associated with increased heterochromatin structures and epigenetic markers including H3K9me2/3. Together, these data implied that the LMNA c.1621C > T/ p.R541C variant enhanced heterochromatic gene suppression and disrupted mitochondria functions as a cause of DCM.
What problem does this paper attempt to address?